Evidence map›Paper›PMID 22128747›Full record

ArticleAging cell2012

Characterization of cellular senescence mechanisms in human corneal endothelial cells.

Angela N Sheerin, S Kaye Smith, Katrin Jennert-Burston, Amy J Brook, Marcus C Allen, Badr Ibrahim, Dawn Jones, Corrin Wallis, Katrin Engelmann, William Rhys-Williams and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Aging cell, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.1field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 31 citations in OpenAlex.

  1. Regenerative therapy · 2025
    Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Angela N SheerinSchool of Pharmacy and Biomolecular Sciences, University of Brighton, Brighton, UK.
S Kaye Smith
Katrin Jennert-Burston
Amy J Brook
Marcus C Allen
Badr Ibrahim
Dawn Jones
Corrin Wallis
Katrin Engelmann
William Rhys-Williams
Richard G A Faragher
David Kipling
University of Brighton · GBCardiff University · GBOphthalmology Clinic · DE

Funding

Biotechnology and Biological Sciences Research Council C18995Biotechnology and Biological Sciences Research Council EGH16151Biotechnology and Biological Sciences Research Council EGH16152
6 · The paper itself

Abstract

The human cornea is a tri-laminar structure composed of several cell types with substantial mitotic potential. Age-related changes in the cornea are associated with declining visual acuity and the onset of overt age-related corneal diseases. Corneal transplantation is commonly used to restore vision in patients with damaged or diseased corneas. However, the supply of donor tissue is limited, and thus there is considerable interest in the development of tissue-engineered alternatives. A major obstacle to these approaches is the short replicative lifespan of primary human corneal endothelial cells (HCEC). Accordingly, a comprehensive investigation of the signalling pathways and mechanisms underpinning proliferative lifespan and senescence in HCEC was undertaken. The effects of exogenous human telomerase reverse transcriptase expression, p53 knockdown, disruption of the pRb pathway by over-expression of CDK4 and reduced oxygen concentration on the lifespan of primary HCEC were evaluated. We provide proof-of-principle that forced expression of telomerase, when combined with either p53 knockdown or CDK4 over-expression, is sufficient to produce immortalized HCEC lines. The resultant cell lines express an HCEC-specific transcriptional fingerprint, and retain expression of the corneal endothelial temperature-sensitive potassium channel, suggesting that significant dedifferentiation does not occur as a result of these modes of immortalization. Exploiting these insights into proliferative lifespan barriers in HCEC will underpin the development of novel strategies for cell-based therapies in the human cornea.

Indexed as

Cellular SenescenceCells, CulturedCyclin-Dependent Kinase 4Endothelial CellsEndothelium, CornealHumansOxidative StressTranscriptomeTumor Suppressor Protein p53CDK4 protein, humanCyclin-Dependent Kinase 4TP53 protein, humanTumor Suppressor Protein p53

Identifiers

PMID22128747
PMCPMC3440103
OpenAlexW1602153797

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.